Laura Lovett
Volition Capital and Greycroft led the round with participation from Horsley Bridge and Lerer Hippeau.
The plan is to eventually roll out 20 such centers across the country.
The company is also looking to fast-track its opioid use disorder therapy, thanks to relaxed FDA guidelines.
Also: Soterix Medical gets green light from FDA to trial its take-home transcranial direct-current stimulation therapy, while MammoScreen gets a 510(k).
Providers can tap into the tool for resources and collaboration.
Also: Tyto Care names Colleen Sellers VP of marketing and MedSign adds John Kastanis to its senior advisory board.
The report indicates that fertility-focused startups have raised $2.2 billion in the last five years.
The co-packaged product, which will be launched in Europe this year, combines Propeller's sensor tech and Novartis' new medication.
Telehealth and digital behavioral health were two of the most popular investment areas.
The new devices can link to the MyMerlinPulse app and give doctors information about a patient's heart health.